Probiotics as treatment for bacterial vaginosis
Transcription
Probiotics as treatment for bacterial vaginosis
@ Probiotics as Treatment for Bactenal Vaginosis NUTR 302 L Jeniffer Beadles, Alexandra Salcedo, Ashley Corbett, Mandy Bakker /bc Probiotics as Treatment for Bacterial Vaginosis I. Specific Aims A. Purpose: The purpose of this study is to examine the effects of the probiotic Lactobacillus acidophilr.rs (found in yogurl) on restoring the vaginal microbiota, maintaining a desirable vaginai pH of 3.5-4.8, and treating bacterial vaginosis in women of reproductive age. B. Objectives: To determine if eight weeks of probiotic (Lactobacillus acidophilus) treatment restores the 1. rnicrobial flora of women suffering from bacterial vaginosis. To determine if eight weeks of probiotic treatment notmalizes vaginal pH to the range of 2. 3.5-4.8. To detennine if consuming probiotics regularly is an effective treatment for bacterial J. vagmosls. C. Hypothesis: It is exPected that consuming the Lactobacillus acidophilrrs found in yogurt for eight weeks will effectively treat bacterial vaginosis by restoring the vaginal microbial flora and pH. II. Background & Significance A. Women's Health: The vaginal microbiota is crucial for every woman's general reproductive health. The vagina's microbial flora is predominantly made of a variety of Lactobacillus bacteria (such as Lactobacillus acidophilas), but when pathogenic vaginal bacteria replace the Lactobacillus species, uritogenital infections can occur (3). Additionally, pathogenic bacteria will raise vaginal pH to optimal levels for their own growth (pH 6-7), thus rnaking it difficult for Lactobacilli to grow and re-colonize the area (7). Around one million women are infected with urogenital infections annually (6). Furthermore, according to Ling et.al, "bacterial vaginosis is the most common disorder in women of reproductive age" (5). Because of this, it is important to research different possible treatments and detennine their efficacy in treating bacterial vaginosis and preventing recurring infections. Research has shown that probiotics can ','A'' be used to treat urogenital infections by introducing Lactobacillus rlrumno.\us and Lactobacillus .fennentunt into the vagina (3). These probiotics will colonize the sunounding tissues and attack uropathogens such as Gardnet"ella vaginalrs (an organism that commonly causes bacterial vaginosis) in order to elirninate the infection (5). This study aims to detemrine if olal ingestion of Lac:tobacillus acidophilus in yogurt is an effective method to nonnalize vaginal pH, restore the vaginal microbiota, and treat bacterial vaginosis. B. Probiotics: Thc health benefits of regularly consuming yogurt are numerous. For example, many consume yogurt because the probiotics it contains aid gastrointestinal function (1). The effect of yogurt and probiotics on other areas of the human body has also been studied. Research has demonstrated that adrninistering probiotic pills aids in preventing and trcating urovaginal infections (8,6,5,3). Curently, there is not enough evidence or research to conclude that bacterial vaginosis can be treated and prevented by consuming Lactobacillus species orally in yogurt products (8). This study aims to explore this area of research, and detennine if the probiotics found yogurt (such as Lactobacillus ac'idoplilus) can be used as an effective treatment for bacterial vaginosis. C. Benefits: Antibiotic resistant bacteria public health that has continued to rapidly grow over the years (4). Due to the overuse and misuse of antibiotics by the general public, pathogens have evolved into antibiotic resistant forms that make medical advances difficult (4). For example, one study recorded that pathogens in 560/o of bacterial vaginosis patients treated with Clindarnycin exhibited resistance to the antibiotic after treatment (2). In order to avoid further propagation of this issue, it is important to conduc't more research in altemative methods of treating bacterial vaginosis and other urogenital infections in women. Probiotics in yogufi may be a practical and effective way for women to treat and prevent recuring infections, while also avoiding the overuse of antibiotics. III. Research Design & Methods A. Subjects: The subjects used for this study will include women between 20-50 years of age. This age group was selected because it includes most women of reproductive age, who are more likely to develop recurring uritogenital infections. In addition, subjects must cur:rently have bacterial vaginosis. Women who are pregnant, smoke, drink rnore than 4 alcoholic beverages weekly, or are significantly immunocompromised will be excluded from this study. B. Design & Measurement: The study will be conducted as a parallel intervention, using a control group (pasteurized yogufi placebo) and an intervention group (yogurt containing Lactobacillus acidophilus). Tbe intelentions will be carried out during eight weeks in order to ensure that the following parameters are accurately measured: Lactobacillus acidophilus colony fonning units (CFU's/ml-) within the vaginal flora, Gardnerella vaginalis colony forning units (CFU's/ml-) within the vaginal flora, and overall pH of the vaginal area. Data collection will be conducted according to the schedule outlined in the following table: ,'V Table 1. Tirning of Data Collection DATA COLLECTED/TESTS PERFORMED WEEK One week prior to week I of thc interuention will be collected'rn order to incubate selective medium petri dishes and detenline CFU's. pH tests will also be perfonned. Swabs Week l-8 Subjects will consume 17 .6 oz of yogurt or placebo daily, as instructed. Week 9 Subjects will be swabbed and microorganlsms incubated as perfonned previously, in order to determine CFU's/ml. Another pH test will be performed. This data will be compared to the pre-intervention data in order to determine resu and analyze the outcomes obtained. D. Collection Processing/Storage: The swabs collected will be inoculated onto selective mediums (within,petri dishes) imrnediately after collection. The inoculated petri dishes will be incubated at 35oC for 48 hours in order to allow the organisms to grow for accurate CFU estimates. After data has been collected, the petri dishes must be discarded and labeled as biohazardous material. This procedure post-intervention samples. will be followed for both pre-intervention and I xl"u'' E. Procedure: Subjects will be screened in order to ensure they meet the specified criteria by requiring refenals from rnedical practitioners or lab results indicating the subjects are infected with bacterial vaginosis. In addition, the subjects will regarding their medical history and demographics. Participants complete a brief questionnaire will also sign waivers in order to remind them of the procedures they are agreeing to follow during the study and what these procedures consist of. Subiects will participate as volunteers for the study, and will be recruited from local health centers and hospitals. Once test subjects have been determined (total of 20) their vaginal areas will be swabbed twice in order to inoculate petri dishes. The petri dishes will be incubated at 35"C for 48 hours. Lactobacillus-MRS Agar and HBT Agar will be used in the petri dishes to isolate Lactobacillus acidophilus and Gardnerella vaginalis colonies, respectively, and detennine CFU'S/nL in order to estimate the number of each organism present within the area. Colony fonning units will be determined by entering pictures of each incubated petri dish into the computer program OpenCFU. Additionally, a pH test of the vaginal area will be performed (using pHEM-ALERT vaginal pH test strips) aftcr the subjccts are swabbed. At the beginning of week The twenty subjects will 1, subjects will begin consuming the items they were be divided into two groups of ten people, each assigned a specific item they must consume daily for the duration of the testing. Group fomrations and placebo/test yogurt groups will assigned. will be randornized will be administered using the double-blind mcthod. In addition, both receive the placebo/test yogurt in the same kind of packaging, so neither thc participants nor the administrators can distinguish between them. The placebo will consist of pasteurized (0% fat FAGE) yogurt which eliminates live cultures, and further ensures that botlt sarnples have the same appearance. Group A (intervention group) will consume fat plain FAGE yogurt per day. Group B (control group) fat plain FAGE yogurl per day. Both groups will will consum e 17 .6 oz 17 .6 oz of 0o/o of pasteurized 0o/o consume a total of 260 calories, 469 protein, and 18g carboliydrate daily fiom the yogurt. Only Group A will consume live and active L.acidophilas cultures, at a minimum of 100 million cultures per gram, as indicated by the "Live and Active" seal on the packaging (a seal issued by the National Yogurt Association to products that contain the required minimum arnount of live cultures). At the end of.the 8 week period, subjects will return for further analysis. Vaginal areas will be swabbed, bactcria isolated, CFU's detennined, and pH tests conducted as described previously. F. Statistical Analysis: The collected data frorn both groups will include: Pre and Post interuention CFU's/rnl of Lactobacillus acidophilus,Pre and Post interuention CFU's/ml- of Gardnerella vaginalis, Pre and Post intervention pH. The values obtained for Group A and Group B will be averaged and compared in order to detennine if the intervention caused signihcant changes in the subjects. Analysis of the data will allswer the following questions regarding the paraneters studied: Did treatment increase/decrease the CFU's/mL of L.acidophilus within the vaginal area? 2) Did treatment increase/decrease CFU's/ml- of G.vaginalrs within the vaginal area? 3) Were vaginal pH values restored to normal, healthy levels? (ph 3.5-a.8) 1) Significance will be dctennined at a p-value of p < 0.05 , in order to ensure obtained as a results of the study, and not by chance. data was { O//Y. 0J* Gf' .ro 'Urr\t f ' \ )'"f ' I ry. Budget: Item ltems required Total Price Vaginal pH testing strips (pHEM-ALERT) 4 boxes (12 count box), $45.95 each $ Puritan cotton Ob/Gyn swabs I box (50 count) $7.89 Fage yogurl, plain, lYo fat, 17. 50 containers, 65 per person, $5.99 each $6,888.5 OZ 1,1 Lactobacillus MRS Agar Plate 4 packs (10 count), $10.45 183.8 $41.80 each 4 packs (10 couut) $102.60 HBT Agar Plates $410.40 each I s519.00 Latex powder free-gloves 3 boxes (100 count) $9.25 each s27.7s Employee salaries 8 employees, $10.00/hr, 160 $ Therrno scientific microbiological incubator 12.800 hours total 40 days, M-F during 8 weeks, $100 daily $4.000 SDSU Computer Lab Space 40 days, M-F during 8 weeks, $75 daily $3,000 H&M commercial Dairy Milk Pasteurizer HMIX 30Cp-236w I $1 1,798 I $91.7s SDSU Microbiology Lab Space (including microscopes and facilities) 10 Gallon Biohazard Bin Total Cost: $39,768.39 Total Budget: $45,000 IV. References l. Adolfsson Oskar, Meydani Simin, and Russel Robert. Yogurt and Gut Function. The American Journal of Clinical Nutrition. 2004; 80(2):245 -25 6. Available fiom: ajcn.nutrition.org, Accessed: February I 8th 2. Beigi Richard, Austin Michelle, Meyn Leslie, et al. Antimicrobial resistance associated with the treatment of bacterial vaginosis. American Journal of Obstetrics and Gynecology. 2004; 19l(4):1124-1129. Available from: ScienceDirect, Accessed: February l8th i 3. Burton Jeremy P., Peter A. Cadieux, and Gregor Reid. Improved Understanding of the Bacterial Vaginal Microbiota of Women before and after Probiotic Instillation. Applied and Environmental Microbiology. 2003 ; 69 (l) :97 - I 0 | . Available from: American Society for Microbiology, Accessed: February 4th 4. Levy Stuart. Factors impacting on the problem of antibiotic resistance . Journal of Antimicrobial Chemotherapy. 2002;a9 () :25 -3 0 . Available on: Oxford Journals, Accessed: February 18th. 5. Ling Zongxin, Chen Weiguang, Luo Yueqiu, et al. The Restoration of the Vaginal Microbiota After Treatment for Bacterial Vaginosis with Metronidazole or Probiotics. Microbial Ecology. 2013; 65(3):773-780. Available on: Springer Link, Accessed: February 4th 6. Reid G, Owen J, Heinemann C, Henning B, Fraser N, Bruce AW. Oral probiotics can resolve urogenital infections. FEMS Immunology & Medical Microbiology. 200I;30(l):49-52. Available on: PubMed, Accessed: February 3rd 7. Robinson Taylor. The relation between vaginal pH and the microbial status in vaginitis. International Journal of Obstetrics and Gynecology. 1985;92(12):1267 -1271 . Available on: Wiley Online Library, Accessed: February 18th 8. Ya Wang MD, Reifer Cheryl PhD, MillerLarry PhD. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. American Journal of Obstetrics and Gynecology. 20 l0 ; 203(2):120-121 Available on: PubMed, Accessed: February 5th .